Skip to main content

Table 1 Baseline characteristics of intent-to-treat patients included in the clinical trial

From: Intra-articular platelet-rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis: a single-center prospective randomized controlled study with a 1-year follow up

 

PRP group (N = 20)

Corticosteroid group (n = 20)

p value

Gender, M:F, n

17:3

15:5

ns

Age, years, mean/SD

66.4 ± 8.4

70.2 ± 9.2

ns

BMI, mean/SD

28.6 ± 5.0

30.5 ± 5.8

ns

K-L degree (II/III), n

5:15

6:14

ns

Knee (right/left), n (%)

14/6 (70%/30%)

12/8 (60%/40%)

ns

VAS baseline, mean/SD

6.1 ± 1.2

6.0 ± 1.4

ns

KSS baseline, mean/SD

58.3 ± 7.2

54.0 ± 8.2

ns

IKDC baseline, mean/SD

36.6 ± 10.4

30.0 ± 8.8

0.0377

  1. Data are provided as mean ± SD (range), unless indicated otherwise
  2. BMI body mass index, K-L, Kellgren-Lawrence classification radiographically confirmed, VAS visual analog scale, KSS Knee Society Score, IKDC International Knee Documentation Committee, ns not significant
Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X